Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond
ATM
BRCA1
BRCA2
CHECK2
PALB2
PTEN
bilateral breast cancer
breast cancer
germline pathogenic variants
multi-gene panel testing
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Aug 2020
25 Aug 2020
Historique:
received:
23
07
2020
revised:
23
08
2020
accepted:
24
08
2020
entrez:
29
8
2020
pubmed:
29
8
2020
medline:
29
8
2020
Statut:
epublish
Résumé
Patients with unilateral breast cancer (UBC) have an increased risk of developing bilateral breast cancer (BBC). The annual risk of contralateral BC is about 0.5%, but increases by up to 3% in
Identifiants
pubmed: 32854451
pii: cancers12092415
doi: 10.3390/cancers12092415
pmc: PMC7564956
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Genet Med. 2014 Nov;16(11):830-7
pubmed: 24763289
Ann Oncol. 2015 Sep;26 Suppl 5:v8-30
pubmed: 26314782
Cancer Res. 2008 Apr 1;68(7):2154-7
pubmed: 18381420
Cancers (Basel). 2020 May 05;12(5):
pubmed: 32380732
Breast Cancer Res Treat. 2017 Jun;163(2):383-390
pubmed: 28281021
Cancer Treat Rev. 2015 Jan;41(1):1-8
pubmed: 25467110
Cancer Med. 2019 Jun;8(6):2908-2918
pubmed: 31038845
J Natl Cancer Inst. 2016 Sep 06;109(1):
pubmed: 27601060
J Natl Compr Canc Netw. 2018 Nov;16(11):1362-1389
pubmed: 30442736
J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6
pubmed: 10433620
Eur J Cancer. 2009 Nov;45(17):3000-7
pubmed: 19744851
Cancer Res Treat. 2020 Jul;52(3):697-713
pubmed: 32019277
ANZ J Surg. 2018 Oct;88(10):982-987
pubmed: 30141242
Biomed Res Int. 2013;2013:747318
pubmed: 23586058
Oncotarget. 2017 Jul 18;8(29):47064-47075
pubmed: 28423363
Eur J Cancer. 2019 Jan;106:54-60
pubmed: 30471648
Ann Oncol. 2019 Oct 1;30(10):1558-1571
pubmed: 31378807
J Clin Diagn Res. 2015 Sep;9(9):XC05-XC08
pubmed: 26500995
PLoS One. 2013 Jun 06;8(6):e62692
pubmed: 23762227
JAMA Oncol. 2015 Oct;1(7):943-51
pubmed: 26270727
J Clin Oncol. 2014 Jul 1;32(19):2001-9
pubmed: 24733792
Hum Mutat. 2008 Nov;29(11):1282-91
pubmed: 18951446
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Hum Mutat. 2016 Jun;37(6):564-9
pubmed: 26931183
J Clin Oncol. 2012 Dec 10;30(35):4308-16
pubmed: 23109706
Eur J Breast Health. 2020 Apr 01;16(2):129-136
pubmed: 32285035
J Clin Oncol. 2007 Sep 20;25(27):4210-6
pubmed: 17878475
N Engl J Med. 2015 Jun 4;372(23):2243-57
pubmed: 26014596
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Nature. 1995 Dec 21-28;378(6559):789-92
pubmed: 8524414
Breast J. 2020 Jul;26(7):1337-1342
pubmed: 31999039
Breast Cancer Res. 2012 Apr 20;14(2):401
pubmed: 22520019
NPJ Breast Cancer. 2017 Jun 9;3:22
pubmed: 28649662
Br J Cancer. 2011 Apr 26;104(9):1384-92
pubmed: 21487411
Breast Cancer Res Treat. 2004 Jan;83(1):91-3
pubmed: 14997059
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Breast Cancer Res Treat. 2009 Jan;113(1):67-70
pubmed: 18228134
J Clin Oncol. 2009 Dec 10;27(35):5887-92
pubmed: 19858402
Science. 1994 Oct 7;266(5182):66-71
pubmed: 7545954
JAMA Surg. 2017 Jun 1;152(6):589-594
pubmed: 28423155
Nat Rev Clin Oncol. 2014 Mar;11(3):157-66
pubmed: 24492834
J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65
pubmed: 12237281
Cancer. 2015 Jan 1;121(1):25-33
pubmed: 25186627
EPMA J. 2010 Sep;1(3):397-412
pubmed: 23199084